Chairman Dag Dvergten has today through his wholly owned company Dag Dvergsten AS ("DDAS") sold 93,104 shares in CellCura ASA at an average price of NOK 0.21 per share. As a result of the transaction DDAS' shareholding in CellCura will decrease to 48 670 379 shares, constituting 90.10 per cent of the shares and votes in CellCura. In addition, DDAS has the right to subscribe for up to 16 454 512 further shares in CellCura if the remaining part of the outstanding convertible loan is converted at maturity.

Oslo, 22 December 2014
CellCura ASA
Tore Viana-Rønningen
Chief Executive Officer
Phone: + 47 911 08 693

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

distributed by